EMEA-002950-PIP01-20
Key facts
Invented name |
Lutathera
|
Active substance |
lutetium (177Lu) oxodotreotide
|
Therapeutic area |
Oncology
|
Decision number |
P/0503/2021
|
PIP number |
EMEA-002950-PIP01-20
|
Pharmaceutical form(s) |
Solution for infusion
|
Condition(s) / indication(s) |
Treatment of gastroenteropancreatic neuroendocrine tumours
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Advanced Accelerator Applications
Email: infomed@adacap.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|